Massachusetts General Hospital Cancer Center SC — Boston, Massachusetts

Massachusetts General Hospital Cancer Center SC is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Cancer Center SC has participated in 1 clinical trials.

Therapeutic areas: Advanced Triple Negative Breast Cancer (TNBC) With High TAMs.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Cancer Center SC?

Massachusetts General Hospital Cancer Center SC has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Cancer Center SC conducted?

Massachusetts General Hospital Cancer Center SC has 1 clinical trials on record. Their work covers Advanced Triple Negative Breast Cancer (TNBC) With High TAMs.

Is Massachusetts General Hospital Cancer Center SC accredited by Crixeo Health?

Massachusetts General Hospital Cancer Center SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Cancer Center SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.